American BriVision (Holding) ABVC
American BriVision (Holding) appoints Mr. Chihliang An as Chief Financial Officer
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001213900-19-016730
- Document
- 8-K
- Sells unregistered shares (3.02)
- Reports an executive or board change (5.02)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Karyopharm Therapeutics KPTI public float $37M, Jun 30, 2025
- BriaCell Therapeutics BCTX public float $37M, Jan 30, 2026
- Annovis Bio ANVS public float $36M, Jun 30, 2025
- Atara Biotherapeutics ATRA public float $39M, Jun 30, 2025
- Grace Therapeutics GRCE public float $35M, Sep 30, 2025
